PharmaCielo Announces the Appointment of Cannabis Industry Veterans Bob DeGabrielle and Will Nicholas to the Company’s Board
- DeGabrielle was an early entrepreneur and executive in the U.S. cannabis industry; he founded and owned Los Sueños Farms LLC, the largest outdoor grow in North America. He recently agreed to sell to Curaleaf Inc.
- Nicholas is an experienced finance professional and an early investor in the global cannabis industry; he was one of the founding shareholders of Alternative Medical Enterprises LLC, which merged with Verano Holdings LLC in December 2020.
TORONTO, Canada and RIONEGRO, Colombia (September 1, 2021) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that two experienced cannabis market professionals – Bob DeGabrielle and Will Nicholas – have been added to the Company’s board of directors. Bob DeGabrielle is an experienced entrepreneur and operator in the sector, and Will Nicholas is a successful long-term investor in the space.
Bill Petron, Chairman, and CEO of PharmaCielo Ltd., commented, “As we focus on taking one of the largest, lowest cost cannabis operations in the world, and quickly leveraging it into a position of global leadership, we need to have the right talent and guidance around the table. Bob brings experience at every level of the cannabis value chain, with particular expertise gained from founding, scaling, and monetizing the largest outdoor cannabis cultivation footprint in North America. In addition, it will bring a very sophisticated global finance perspective, having funded some of the most promising assets in the developing global cannabis industry and helped build them into enduring businesses that create lasting shareholder value.”
Background – Bob DeGabrielle
After a lengthy career in acquiring, developing, and selling over US$1 billion of commercial and residential real estate in the Outer Banks of North Carolina, Bob DeGabrielle became a pioneer in the cannabis industry.
His involvement in the industry began in Florida, where he was instrumental in assisting with the Cannabis Ballot Initiative, which passed in 2012. After his successful efforts on the East Coast, he moved to Colorado, where he built three dispensaries, a testing lab, and a 25,000 sf indoor cultivation facility. Since 2015, Mr. DeGabrielle has been the managing partner and one of the founders of Los Suenos Farms LLC, the largest outdoor cannabis farm in North America, consisting of 36 acres of sun-grown cannabis and an additional 36,000 sf greenhouses. In addition, he is the owner of High Colorado Farms and Nielsen Farms. Combined, all three farms consist of over 66 acres and are currently growing 60,000 plants that should produce more than 90,000 pounds of biomass in 2021. Additionally, Mr. DeGabrielle is the owner of Colorado Cannabis Associates, two retail dispensaries, and an additional indoor cultivation facility.
He serves on the board of Colorado Leads and MIG (Marijuana Industry Group), the two leading cannabis industry associations in Colorado. Mr. DeGabrielle was also a founding member of the Cannabis Trade Federation, a national industry association in the United States.
In May 2021, it was announced that Curaleaf, Inc. acquired Curaleaf, Inc. acquired Curaleaf, Inc. acquired these combined business interests for US$78 million. The transaction is expected to close in late 2021.
Background – Will Nicholas
Will Nicholas is an experienced finance professional with an extensive career in banking and investment management in New York, Zurich, and London. Following a career in banking with Bankers Trust Company, Swiss Bank Corporation, and UBS Investment Bank, Mr. Nicholas co-founded Oceanwood Capital Management, a London-based European-focused event-driven hedge fund manager. Mr. Nicholas served as COO and then CEO of the firm for over a decade and retired as CEO in 2017.
In 2014, Mr. Nicholas performed extensive research on the burgeoning U.S. medical cannabis industry, which led to him becoming a “day 1” investor in Alternative Medical Enterprises (“AltMed”). In addition, Mr. Nicholas provided AltMed with strategic advice on the European medical cannabis market before its merger with Verano Holdings Corp. Mr. Nicholas, a resident of Oxford, England, continues to follow developments in the European Medical cannabis market actively and has developed a network of industry contacts in the UK, Germany, Poland, Portugal, and the Czech Republic.
PharmaCielo Ltd. (TSXV: PCLO, OTCQX: PCLOF) is a global company headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all-natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo’s principal (and wholly-owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its cultivation and processing center located in Rionegro, Colombia.
The board of directors and executive team of PharmaCielo are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia’s ideal location plays in building a sustainable business in the medical cannabis industry. Together with its directors and executives, the company is executing a business plan to supply the international marketplace.
For further information:
Ian Atacan, Chief Financial Officer
International: Gal Wilder, Cohn & Wolfe